Jaguar Health Inc (JAGX)
1.20
+0.04
(+3.00%)
USD |
NASDAQ |
Sep 27, 16:00
1.18
-0.02
(-1.67%)
After-Hours: 20:00
Jaguar Health SG&A Expense (TTM): 22.00M for June 30, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 22.00M |
March 31, 2024 | 22.18M |
December 31, 2023 | 23.05M |
September 30, 2023 | 22.45M |
June 30, 2023 | 23.94M |
March 31, 2023 | 24.42M |
December 31, 2022 | 26.70M |
September 30, 2022 | 28.92M |
June 30, 2022 | 28.65M |
March 31, 2022 | 29.42M |
December 31, 2021 | 25.99M |
September 30, 2021 | 24.09M |
June 30, 2021 | 23.70M |
March 31, 2021 | 21.93M |
December 31, 2020 | 21.00M |
September 30, 2020 | 21.13M |
June 30, 2020 | 20.09M |
March 31, 2020 | 19.98M |
December 31, 2019 | 20.44M |
September 30, 2019 | 21.48M |
Date | Value |
---|---|
June 30, 2019 | 22.10M |
March 31, 2019 | 22.48M |
December 31, 2018 | 22.11M |
September 30, 2018 | 20.76M |
June 30, 2018 | 19.07M |
March 31, 2018 | 15.62M |
December 31, 2017 | 14.33M |
September 30, 2017 | 11.25M |
June 30, 2017 | 8.767M |
March 31, 2017 | 7.942M |
December 31, 2016 | 6.469M |
September 30, 2016 | 6.476M |
June 30, 2016 | 6.780M |
March 31, 2016 | 6.773M |
December 31, 2015 | 6.104M |
September 30, 2015 | 5.203M |
June 30, 2015 | 5.103M |
March 31, 2015 | 4.885M |
December 31, 2014 | 4.095M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
19.98M
Minimum
Mar 2020
29.42M
Maximum
Mar 2022
23.58M
Average
22.75M
Median
SG&A Expense (TTM) Benchmarks
Perspective Therapeutics Inc | 18.64M |
Alaunos Therapeutics Inc | 8.613M |
Oragenics Inc | 6.283M |
Cocrystal Pharma Inc | 5.596M |
Chimerix Inc | 24.55M |